Literature DB >> 19213572

Aspirin and NSAIDs for the prevention of colorectal cancer.

John A Baron1.   

Abstract

With few exceptions, epidemiological studies have found that individuals who take nonsteroidal antiinflammatory drugs (NSAIDs) have a reduced risk of colorectal adenomas and carcinoma. Similarly, randomized studies in patients with familial adenomatous polyposis have uniformly found that NSAIDs can lead to polyp regression and prevention of new polyps, and trials in patients with sporadic adenomas document that aspirin reduces the risk of adenoma recurrence. Together these data provide convincing evidence for the chemopreventive efficacy ofNSAIDs in the large bowel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19213572     DOI: 10.1007/978-3-540-69297-3_21

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  24 in total

1.  The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.

Authors:  G Xie; T Nie; G G Mackenzie; Y Sun; L Huang; N Ouyang; N Alston; C Zhu; O T Murray; P P Constantinides; L Kopelovich; B Rigas
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

Authors:  Xinwei Hua; Amanda I Phipps; Andrea N Burnett-Hartman; Scott V Adams; Sheetal Hardikar; Stacey A Cohen; Jonathan M Kocarnik; Dennis J Ahnen; Noralane M Lindor; John A Baron; Polly A Newcomb
Journal:  J Clin Oncol       Date:  2017-06-15       Impact factor: 44.544

3.  Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.

Authors:  Anna E Coghill; Polly A Newcomb; Peter T Campbell; Andrea N Burnett-Hartman; Scott V Adams; Elizabeth M Poole; John D Potter; Cornelia M Ulrich
Journal:  Gut       Date:  2010-11-04       Impact factor: 23.059

4.  The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac.

Authors:  Xingya Wang; Philip J Kingsley; Larry J Marnett; Thomas E Eling
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

5.  Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agents.

Authors:  Yu Sun; Liqun Huang; Gerardo G Mackenzie; Basil Rigas
Journal:  J Pharmacol Exp Ther       Date:  2011-06-06       Impact factor: 4.030

6.  Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry.

Authors:  Alexa J Resler; Karen W Makar; Laura Heath; John Whitton; John D Potter; Elizabeth M Poole; Nina Habermann; Dominique Scherer; David Duggan; Hansong Wang; Noralane M Lindor; Michael N Passarelli; John A Baron; Polly A Newcomb; Loic Le Marchand; Cornelia M Ulrich
Journal:  Carcinogenesis       Date:  2014-06-07       Impact factor: 4.944

7.  The association between NSAID use and colorectal cancer mortality: results from the women's health initiative.

Authors:  Anna E Coghill; Amanda I Phipps; Anthony A Bavry; Jean Wactawski-Wende; Dorothy S Lane; Andrea LaCroix; Polly A Newcomb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-29       Impact factor: 4.254

8.  Priming effect of aspirin for tumor cells to augment cytotoxic action of cisplatin against tumor cells: implication of altered constitution of tumor microenvironment, expression of cell cycle, apoptosis, and survival regulatory molecules.

Authors:  Anjani Kumar; Sukh Mahendra Singh
Journal:  Mol Cell Biochem       Date:  2012-08-15       Impact factor: 3.396

9.  Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors.

Authors:  Karen J Wernli; John M Hampton; Amy Trentham-Dietz; Polly A Newcomb
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11-08       Impact factor: 2.890

Review 10.  The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.

Authors:  Yong Lin; Lang Bai; Wenjie Chen; Shanling Xu
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.